| AAS | Atomic absorption spectrometry |
| A549 | Human lung cancer cell line model |
| ABTS | 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) |
| ABTS•+ | ABTS radical cation |
| AgNPs | Silver nanoparticles |
| Akt | Protein Kinase B |
| ALA | Alpha-linolenic acid |
| AOAC | Association of Official Analytical Collaboration |
| AR | Androgen receptor |
| Bax | Bcl-2-associated X protein (Proapoptotic) |
| Bcl-2 | B-cell lymphoma (Antiapoptotic) |
| BGC-823 | Gastric carcinoma cell line model |
| CaA | Capric acid |
| CaCo-2 | Colorectal adenocarcinoma for cell line model |
| Caspase | Cysteine-aspartic protease |
| C-33A | Human uterine cancer cell line model |
| CBFMS | Community-based forest management |
| COX2 | Cycloooxygenase-2 |
| CSCs | Cancer Stem Cells |
| CVD | Cardiovascular diseases |
| DAD | Diode array detector |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl (stable free radical) |
| DU145 | Human prostate cancer cell line model |
| DW | Dry weight |
| EC50 | Half (50%) maximal effective concentration |
| EO | Essential oils |
| FRAP | Ferric reducing antioxidant power |
| FW | Fresh weight |
| G1 phase arrest | Pause in the cell cycle before the S phase, triggered by cell stress, DNA damage, or lack of growth factors |
| GAE | Gallic acid equivalent |
| GC | Gas chromatography |
| GI50 | Half (50%) maximal growth inhibitory concentration |
| H1299 | Non-small cell lung carcinoma cell line model |
| HCT-116 | Colorectal carcinoma cell line model |
| HeLa | Cervical cancer cell line model |
| HepG2 | Liver hepatocellular carcinoma cell line model |
| HL-60 | Promyelocytic leukemia cell line model |
| HPLC | High-performance liquid chromatography |
| HPTLC | High-performance thin-layer chromatography |
| HT-29 | Human colorectal adenocarcinoma cell line model |
| IC50 | Half (50%) maximal inhibitory concentration |
| ICP-MS | Inductively coupled plasma mass spectroscopy |
| ICP-OES | Inductively coupled plasma optical emission spectroscopy |
| IFN-γ | Interferon gamma |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IL-12 | Interleukin-12 |
| JAK | Janus Kinase |
| LaA | Lauric acid |
| LA | Linoleic acid |
| LNCaP: | Prostate carcinoma (Lymph Node) cell line model |
| MCF-7 | Human breast cancer cell line model |
| MDA-MB-231 | Triple-negative breast cancer cell line model |
| MIC | Minimum inhibitory concentration |
| Mia PaCa-2 | Human pancreatic cancer cell line model |
| MMP | Matrix Metalloproteinase |
| mTOR | Mammalian Target of Rapamycin |
| NCI-H460 | Large cell lung carcinoma cell line model |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| OA | Oleic acid |
| OVCAR-3 | Ovarian carcinoma cell line model |
| PA | Palmitic acid |
| PANC-1 | Human pancreatic epithelioid carcinoma cell line model |
| PARP | Poly (ADP-ribose) polymerase |
| PC-3 | Prostate cancer cell line model |
| PGE2 | Prostaglandin E2 |
| PICO | Population; intervention; comparator; outcome |
| PI3K | Phosphoinositide 3-kinase |
| PLA2 | Phospholipase A2 |
| POA | Palmitoleic acid |
| PK | Mitogen-Activated Protein Kinase |
| ROO• | Peroxyl free organic radical |
| ROS | Reactive oxygen species |
| SA | Stearic acid |
| SKOV3 | Ovarian adenocarcinoma cell line model |
| SNA | Sambucus nigra Agglutinin (Lectin) |
| STAT | Signal Transducer and Activator of Transcription |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| T47D | Breast ductal epithelial tumor cell line model |
| TBARS | Thiobarbituric acid reactive substances |
| TEK | Traditional ecological knowledge |
| TLR4 | Toll-Like Receptor 4 |
| TNF-α | Tumor necrosis factor alpha |
| TPA | 12-O-tetradecanoylphorbol-13-acetate |
| TRP | Transient Receptor Potential |
| TRPA1 | Transient Receptor Potential Ankyrin 1 |
| TRPV1 | Transient Receptor Potential Vanilloid 1 |
| U-87 | Human glioblastoma cell line model |
| UVB | Ultraviolet B |
| VEGF | Vascular Endothelial Growth Factor |
| WEFs | Wild Edible Fruits |